3-Dehydroquinic Acid

Identification

Generic Name
3-Dehydroquinic Acid
DrugBank Accession Number
DB03868
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 190.1507
Monoisotopic: 190.047738052
Chemical Formula
C7H10O6
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
U3-dehydroquinate dehydrataseNot AvailableHelicobacter pylori (strain ATCC 700392 / 26695)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Hydroxy acids and derivatives
Sub Class
Alpha hydroxy acids and derivatives
Direct Parent
Alpha hydroxy acids and derivatives
Alternative Parents
Cyclitols and derivatives / Tertiary alcohols / Secondary alcohols / Cyclic ketones / Polyols / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives
Substituents
Alcohol / Aliphatic homomonocyclic compound / Alpha-hydroxy acid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Cyclic alcohol / Cyclic ketone / Cyclitol or derivatives / Hydrocarbon derivative
Molecular Framework
Aliphatic homomonocyclic compounds
External Descriptors
4-oxo monocarboxylic acid, 5-hydroxy monocarboxylic acid, 4-hydroxy monocarboxylic acid, 2-hydroxy monocarboxylic acid (CHEBI:17947)
Affected organisms
Not Available

Chemical Identifiers

UNII
Q8HL497GUU
CAS number
Not Available
InChI Key
WVMWZWGZRAXUBK-SYTVJDICSA-N
InChI
InChI=1S/C7H10O6/c8-3-1-7(13,6(11)12)2-4(9)5(3)10/h3,5,8,10,13H,1-2H2,(H,11,12)/t3-,5+,7-/m1/s1
IUPAC Name
(1R,3R,4S)-1,3,4-trihydroxy-5-oxocyclohexane-1-carboxylic acid
SMILES
O[C@@H]1C[C@@](O)(CC(=O)[C@H]1O)C(O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0012710
KEGG Compound
C00944
PubChem Compound
439351
PubChem Substance
46508711
ChemSpider
388474
ChEBI
17947
ZINC
ZINC000004095505
PDBe Ligand
DQA
PDB Entries
1j2y / 3m7w / 3nnt / 5ydb / 8idu

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility702.0 mg/mLALOGPS
logP-2ALOGPS
logP-2.1Chemaxon
logS0.57ALOGPS
pKa (Strongest Acidic)3.3Chemaxon
pKa (Strongest Basic)-3.3Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area115.06 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity38.7 m3·mol-1Chemaxon
Polarizability16.46 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.5701
Blood Brain Barrier+0.6547
Caco-2 permeable-0.8106
P-glycoprotein substrateNon-substrate0.5932
P-glycoprotein inhibitor INon-inhibitor0.9594
P-glycoprotein inhibitor IINon-inhibitor0.9907
Renal organic cation transporterNon-inhibitor0.9389
CYP450 2C9 substrateNon-substrate0.8638
CYP450 2D6 substrateNon-substrate0.8992
CYP450 3A4 substrateNon-substrate0.6068
CYP450 1A2 substrateNon-inhibitor0.9833
CYP450 2C9 inhibitorNon-inhibitor0.9748
CYP450 2D6 inhibitorNon-inhibitor0.9598
CYP450 2C19 inhibitorNon-inhibitor0.969
CYP450 3A4 inhibitorNon-inhibitor0.9502
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity1.0
Ames testNon AMES toxic0.9152
CarcinogenicityNon-carcinogens0.9365
BiodegradationNot ready biodegradable0.5074
Rat acute toxicity1.9269 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9917
hERG inhibition (predictor II)Non-inhibitor0.9602
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0596-9300000000-7ead36d659dabf409016
GC-MS Spectrum - EI-BGC-MSsplash10-006t-0964100000-43f6105696288554732d
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0002-1931000000-57530b3291dd2e565178
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-00fr-0900000000-54174802fb64e0b866f3
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-0900000000-e2c7e6c592f9fa31d6f0
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0079-4900000000-1b433c566e45871c8be5
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a6r-5900000000-bd5e7096cb5366fd9d3e
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-9100000000-7a7cd8697f34778cff26
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0avl-9400000000-a72e1cebb41f2e101f6b
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-137.6075567
predicted
DarkChem Lite v0.1.0
[M-H]-138.5660567
predicted
DarkChem Lite v0.1.0
[M-H]-136.12848
predicted
DeepCCS 1.0 (2019)
[M+H]+139.1222567
predicted
DarkChem Lite v0.1.0
[M+H]+139.5123567
predicted
DarkChem Lite v0.1.0
[M+H]+138.32256
predicted
DeepCCS 1.0 (2019)
[M+Na]+137.6920567
predicted
DarkChem Lite v0.1.0
[M+Na]+138.3644567
predicted
DarkChem Lite v0.1.0
[M+Na]+144.23509
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Helicobacter pylori (strain ATCC 700392 / 26695)
Pharmacological action
Unknown
General Function
3-dehydroquinate dehydratase activity
Specific Function
Catalyzes a trans-dehydration via an enolate intermediate.
Gene Name
aroQ
Uniprot ID
Q48255
Uniprot Name
3-dehydroquinate dehydratase
Molecular Weight
18483.21 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52